Super-responders to cardiac resynchronization therapy remain at risk for ventricular arrhythmias and benefit from defibrillator treatment

Author(s):
Heijden, A.C. van der; Hoke, U.; Thijssen, J.; Borleffs, C.J.W.; Rees, J.B. van; Velde, E.T. van der (0000-0002-0027-8059); Schalij, M.J.; Erven, L. van
Published
2014
Publication type
Article / Letter to editor
Cardiac resynchronization therapyLeft ventricular reverse remodellingVentricular arrythmiasImplantable cardioverter-defibrillator
Date issued
2014-10-31
Language
English
Is part of
European Journal of Heart Failure (2014), Vol. 16, no. 10, p. 1104-1111
hdl
1887/103243
doi
10.1002/ejhf.152